Moderna Inc
MRNA
#160

¥1,724.19

13.09%

已结束: Nov 04, 21:00:00 PM UTC+00:00

¥1,718.84

0.31%

盘后: Nov 04, 22:13:24 PM UTC+00:00

Moderna Inc Info

市值: ¥686.22B
0.31%
日交易量: ¥22.46B
市盈率: --
股息率: --
EPS: -¥52.65
52周范围: ¥148.69¥1.73K

网站

www.modernatx.com

币种

股票

员工

5800

创立日期

Sep 1, 2010

主要交易平台

Nasdaq

行业

Biological Products, (No Diagnostic Substances)

CIK 编号

0001682852

代币化股票数据

平均代币化价格: ¥1.71K
价差: +¥1.06(-0.06%)
代币化市值: ¥24.94M
28.52%
代币化交易量（24 小时）: ¥215.61M
30.5%

发行人

bStocks

合约列表

浏览器

etherscan.io

MRNA对美元转换器

MRNA

CNY

价格表现

低
¥1.5K

高
¥1.73K

加载数据中

请稍候，我们正在加载图表数据

Moderna Inc社区

关于Moderna Inc

What is Moderna Inc?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.